NIA 24 SPF 30
- Manufacturer
- Niadyne Inc | Englewood Lab, Inc.
- Effective date
- 2025-02-07
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 10
- Source
- full-release
- Hydrated at
- 2026-06-01 00:54:44
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Purpose Homosalate 7.5%.................................Sunscreen Octisalate 5.0%...................................Sunscreen Avobenzone 3.0%................................Sunscreen Octocrylene 2.6%................................Sunscreen
OTC - PURPOSE SECTION
Uses - for prevention of sunburn
WARNINGS SECTION
Warnings For external use only.
OTC - WHEN USING SECTION
When using this product, keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash or irritation develops and lasts.
OTC - ASK DOCTOR SECTION
For children 6 months of age or under , consult a doctor prior to use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
INDICATIONS & USAGE SECTION
If swallowed, get medical help or contact a poison control center right away.
PRECAUTIONS SECTION
UV exposure from the sun increases the risk of skin cancer, premature skin aging, and other skin damage. It is important to decrease UV exposure by limiting time in the sun, wearing protective clothing, and using a sunscreen.
DOSAGE & ADMINISTRATION SECTION
Directions - Apply a dime sized amount in the morning on cleansed face and neck or over a moisturizer. - Reapply as needed or after towel drying, swimming or perspiring.
INACTIVE INGREDIENT SECTION
Inactive Ingredients Water (Aqua/Eau), Dipropylene Glycol, Myristyl Nicotinate, Polyester-8, Caprylyl Methicone, Cyclomethicone, Glyceryl Stearate, Polyacrylate-15, Panthenol, Potassium Cetyl Phosphate, Butylene Glycol, Mangifera Indica (Mango) Seed Butter, Methyl Glucose Sesquistearate, Hydrogenated Palm Glycerides, Polyacrylate-17, Dipotassium Glycyrrhizate, Glycine Soja (Soybean) Seed Extract, Ceramide 2, Ceramide 3, Lycium Chinensis Fruit Extract, Vaccinium Angustifolium (Blueberry) Fruit Extract, Arctostaphylos Uva Ursi Leaf Extract, PEG-100 Stearate, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Isohexadecane, Sorbitan Sesquioleate, Polysorbate 80, Cetyl Alcohol, Tocopheryl Acetate, Xanthan Gum, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Potassium Hydroxide, Disodium EDTA, Phenoxyethanol, Caprylyl Glycol, Myristica Fragrans (Nutmeg) Kernel Extract.
DESCRIPTION SECTION
Prevention Now Starts From Within. The benefits of NIA 24TM help to prevent, repair and fight the visible signs of sun damage. Skin Cancer Foundation Facts*: - In our lifetime, 1 in 5 Americans will be victims of skin cancer. - More than 90% of all skin cancers are preventable--- caused by sun exposure. - The risk of melanoma has doubled in the past decade. It is responsible for 75% of all skin cancer-related deaths. *These facts have been provided by the Skin Cancer Foundation. - Improve the appearance of sun damage, hyperpigmentation and brown spots. - Reduce the appearance of fine lines and wrinkle. - Improve skin tone, texture and firmness. - See stronger skin with a better self-defense against visible signs of sun damage and moisture loss. Physician Recommended Allergy Tested Fragrace, Color and Dye Free Non-Comedogenic.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NIA 24 Niacin-Powered Skin Therapy Sun Damage Prevention UVA/UVB Sunscreen Micro Nutrient Deliver: NIACHI SPF 30 PA +++ 5% Pro-Niacin Patented Formula For Moderate to Severs Sun Demage
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Active Ingredients: Homosalate (7.5%), Octisalate (5.0%), Avobenzone (3.0%), Octocrylene (2.6%). Uses - for prevention of sunburn Warnings For external use only.When using this product, keep out of eyes. Rinse with water to remove.Stop use and ask a doctor if rash or irritation develops and lasts.For children 6 months of age or under , consult a doctor prior to use.Keep out of reach of children.If swallowed, get medical help or contact a poison control center right away.UV exposure from the sun increases the risk of skin cancer, premature skin aging, and other skin damage. It is important to decrease UV exposure by limiting time in the sun, wearing protective clothing, and using a sunscreen. e 30mL/1 FLUID OZ. Covered by US Patents 6337065, 6552050, 6464992 NIADYNE, INC., Raieigh, NC 27609/BIORUS sprl, 2 rue Rene Descartes, B-7000 Mons, Belgium 866-NIADYNE (642-3963)
www.NIA24.com Made in the USA 12M
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PreDamage PostDamage UnDamage NIA24 Niacin Powered Skin Therapy For Moderate Severe Sun Damage PA +++ Sun Damage Prevention UVA(aging)/UVB(burning) Sunscreen MicroNutrient Delivery: NIACIN SPF 30 PA+++ 5% Pro-Niacin Patented Formula A lightweight, non-greasy lotion with SPF 30 and PA+++ that absorbs instantly into skin. Formulated with powerful ingredients that provide UVA (aging rays) and UVB (burning rays) protection from sun damage while helping to repair the skin barrier. - Continuous, deep delivery of Pro-Niacin strengthens the skin barrier. - Pro-Niacin is clinically shown to visibly improve skin tone, texture and hyperpigmentation. - Broad spectrum protection (UVA/UVB) with the highest PA rating, helps defend skin against free radical attack that weakens and ages the skin. - Mango butter provides balanced moisturization without leaving excess. - Ceramides promote healthy, vibrant skin. - Antioxidants protect skin from oxidative stress. RECOMMENDED SKIN CANCER FOUNDATION DAILY USE * These facts have been provided by the Skin Cancer Foundation e 75mL/2.5 FLUID OZ 0141A1 EXP:01/2013 8 51203 00073 7
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Covered by US Patents 6337065, 6552050, 6464992 NIADYNE, INC., Raieigh, NC 27609/BIORUS sprl, 2 rue Rene Descartes, B-7000 Mons, Belgium For all consumer inquiries, please call 866-NIADYNE (642-3963)
www.NIA24.com Made in the USA 12M NIA24 NIA24 NIA24 NIA24 NIA24 NIA24 NIA24 NIA24 NIA24
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43115-123-01 | 2023-02-17 | C162847 | 48780-1 | f386c64a-3fed-0266-e053-dadaa90a7c1a | NIA 24 SPF 30 |
| 43115-123-02 | 2023-02-17 | C162847 | 48780-1 | f386c64a-3fed-0266-e053-dadaa90a7c1a | NIA 24 SPF 30 |
| 43115-123-01 | 2023-01-30 | C162847 | 48780-1 | f386c64a-3fed-0266-e053-dadaa90a7c1a | NIA 24 SPF 30 |
| 43115-123-02 | 2023-01-30 | C162847 | 48780-1 | f386c64a-3fed-0266-e053-dadaa90a7c1a | NIA 24 SPF 30 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43115-123-01 | NIA 24 SPF 30 | 1 in 1 PACKAGE | LOTION | 1 | 10 | |
| 43115-123-01 | NIA 24 SPF 30 | 30 mL in 1 TUBE | LOTION | 30 | 10 | |
| 43115-123-02 | NIA 24 SPF 30 | 75 mL in 1 TUBE | LOTION | 75 | 10 | |
| 43115-123-02 | NIA 24 SPF 30 | 1 in 1 PACKAGE | LOTION | 1 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| HOMOSALATE | ACTIVE INGREDIENT | V06SV4M95S | 1 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| HOMOSALATE | ACTIVE MOIETY | V06SV4M95S | 1 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| ARCTOSTAPHYLOS UVA-URSI LEAF | INACTIVE INGREDIENT | 3M5V3D1X36 | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| CARBOMER INTERPOLYMER TYPE A (55000 MPA.S)) | INACTIVE INGREDIENT | 59TL3WG5CO | 1 | |
| CERAMIDE 2 | INACTIVE INGREDIENT | C04977SRJ5 | 1 | |
| CERAMIDE 3 | INACTIVE INGREDIENT | 4370DF050B | 1 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| CYCLOMETHICONE | INACTIVE INGREDIENT | NMQ347994Z | 1 | |
| DIPROPYLENE GLYCOL | INACTIVE INGREDIENT | E107L85C40 | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| GLYCYRRHIZINATE DIPOTASSIUM | INACTIVE INGREDIENT | CA2Y0FE3FX | 1 | |
| HYDROGENATED PALM GLYCERIDES | INACTIVE INGREDIENT | YCZ8EM144Q | 1 | |
| ISOHEXADECANE | INACTIVE INGREDIENT | 918X1OUF1E | 1 | |
| LOWBUSH BLUEBERRY | INACTIVE INGREDIENT | G90PX41VP0 | 1 | |
| LYCIUM CHINENSIS FRUIT | INACTIVE INGREDIENT | TG711Q7A1Q | 1 | |
| MANGIFERA INDICA SEED BUTTER | INACTIVE INGREDIENT | 4OXD9M35X2 | 1 | |
| MYRISTYL NICOTINATE | INACTIVE INGREDIENT | 8QWM6I035C | 1 | |
| NUTMEG | INACTIVE INGREDIENT | AEE24M3MQ9 | 1 | |
| PANTHENOL | INACTIVE INGREDIENT | WV9CM0O67Z | 1 | |
| PEG-100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POLYESTER-8 (1400 MW, CYANODIPHENYLPROPENOYL CAPPED) | INACTIVE INGREDIENT | T9296U138P | 1 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 1 | |
| POTASSIUM CETYL PHOSPHATE | INACTIVE INGREDIENT | 03KCY6P7UT | 1 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | 1 | |
| SODIUM POLYACRYLATE (2500000 MW) | INACTIVE INGREDIENT | 05I15JNI2J | 1 | |
| SORBITAN SESQUIOLEATE | INACTIVE INGREDIENT | 0W8RRI5W5A | 1 | |
| SOYBEAN | INACTIVE INGREDIENT | L7HT8F1ZOD | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- NIA 24 SPF 30
- HOMOSALATE, OCTISALATE, AVOBENZONE, OCTOCRYLENE
- WATER
- DIPROPYLENE GLYCOL
- MYRISTYL NICOTINATE
- POLYESTER-8 (1400 MW, CYANODIPHENYLPROPENOYL CAPPED)
- CYCLOMETHICONE
- GLYCERYL MONOSTEARATE
- PANTHENOL
- POTASSIUM CETYL PHOSPHATE
- BUTYLENE GLYCOL
- MANGIFERA INDICA SEED BUTTER
- HYDROGENATED PALM GLYCERIDES
- GLYCYRRHIZINATE DIPOTASSIUM
- SOYBEAN
- CERAMIDE 2
- CERAMIDE 3
- LYCIUM CHINENSE FRUIT
- LOWBUSH BLUEBERRY
- ARCTOSTAPHYLOS UVA-URSI LEAF
- PEG-100 STEARATE
- SODIUM POLYACRYLATE (2500000 MW)
- ISOHEXADECANE
- SORBITAN SESQUIOLEATE
- POLYSORBATE 80
- CETYL ALCOHOL
- XANTHAN GUM
- CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED)
- POTASSIUM HYDROXIDE
- EDETATE DISODIUM
- PHENOXYETHANOL
- CAPRYLYL GLYCOL
- NUTMEG
- HOMOSALATE
- OCTISALATE
- AVOBENZONE
- OCTOCRYLENE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 43115-123 | 43115-123-01, 43115-123-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | LOTION / TOPICAL | 0.3 %w/v | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| SORBITAN SESQUIOLEATE | SORBITAN SESQUIOLEATE | 0W8RRI5W5A | OINTMENT / TOPICAL | 75 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / TOPICAL | 14.02 %w/w | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CREAM / TOPICAL | 0.5 %w/w | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CREAM / TOPICAL | 0.5 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | LOTION / TOPICAL | 15 %w/w | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | AEROSOL, FOAM / TOPICAL | ADJ PH | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / TRANSDERMAL | 296 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | LOTION / TOPICAL | 0.3 %w/v | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | LOTION / TOPICAL | 1140 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | GEL / TOPICAL | 3 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / TOPICAL | 14.02 %w/w | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | LOTION / TOPICAL | 1140 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | LOTION / TOPICAL | 15 %w/w | ||
| SORBITAN SESQUIOLEATE | SORBITAN SESQUIOLEATE | 0W8RRI5W5A | OINTMENT / TOPICAL | 75 mg | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | SYSTEM / TRANSDERMAL | 6 mg | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / BUCCAL | 30 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | AEROSOL, FOAM / TOPICAL | ADJ PH | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| SOYBEAN | SOYBEAN | L7HT8F1ZOD | EMULSION / TOPICAL | 3 %w/w | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / BUCCAL | 30 mg | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / BUCCAL | 30 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / TRANSDERMAL | 296 mg | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | LOTION / TOPICAL | 1140 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | AEROSOL, FOAM / TOPICAL | ADJ PH | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | LOTION / TOPICAL | 15 %w/w | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | SYSTEM / TRANSDERMAL | 6 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | GEL / TOPICAL | 3 mg | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | SYSTEM / TRANSDERMAL | 6 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / TRANSDERMAL | 296 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CREAM / TOPICAL | 0.5 %w/w | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | LOTION / TOPICAL | 0.3 %w/v | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / TOPICAL | 14.02 %w/w | ||
| SOYBEAN | SOYBEAN | L7HT8F1ZOD | EMULSION / TOPICAL | 3 %w/w | ||
| CYCLOMETHICONE | CYCLOMETHICONE | NMQ347994Z | LOTION / TOPICAL | 3510 mg | ||
| SOYBEAN | SOYBEAN | L7HT8F1ZOD | EMULSION / TOPICAL | 3 %w/w | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | GEL / TOPICAL | 3 mg | ||
| SORBITAN SESQUIOLEATE | SORBITAN SESQUIOLEATE | 0W8RRI5W5A | OINTMENT / TOPICAL | 75 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NIA 24 SPF 30 | HOMOSALATE, OCTISALATE, AVOBENZONE, OCTOCRYLENE | Niadyne Inc | e5c9d56f-48b4-4f0e-add6-f73268755b16 | 2025-02-07 | Warnings | 43115-123-02 43115-123-01 43115-123 43115012302 43115012301 2d90c660-1a00-7dc4-e063-6294a90abc18 e5c9d56f-48b4-4f0e-add6-f73268755b16 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


